W El-Matary
Overview
Explore the profile of W El-Matary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stone J, Mehta N, Singh H, El-Matary W, Bernstein C
Fam Cancer
. 2023 Apr;
22(4):413-422.
PMID: 37119510
Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome predisposing affected individuals to gastrointestinal (GI) cancers through a high burden of polyposis. Colorectal cancer rates reach 100% by the age...
2.
Dhaliwal J, Carroll M, deBruyn J, Ricciuto A, Benchimol E, Lawrence S, et al.
J Crohns Colitis
. 2021 Aug;
16(2):216-223.
PMID: 34379117
Background: Canadian-born children of South Asian [SA] ethnicity develop inflammatory bowel disease [IBD] at similar rates to those among Caucasian children. We evaluated the variation in phenotypic spectrum of IBD...
3.
Dhaliwal J, Walters T, Mack D, Huynh H, Jacobson K, Otley A, et al.
J Crohns Colitis
. 2019 May;
14(4):445-454.
PMID: 31136648
Background And Aims: Incidence of paediatric inflammatory bowel disease [IBD] in Canada is among the highest worldwide, and age of onset may be decreasing. In a multicentre nationwide inception cohort...
4.
Mhanni A, Kozenko M, Hartley J, Deneau M, El-Matary W, Rockman-Greenberg C
Mol Genet Metab Rep
. 2016 Mar;
6:13-5.
PMID: 27014572
Gaucher disease (OMIM #230800) is caused by β-glucosidase deficiency and primarily involves the mononuclear phagocyte system (also called Reticuloendothelial System or Macrophage System). The disease is classified into three main...
5.
Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease
Yang C, Singh P, Singh H, Le M, El-Matary W
Aliment Pharmacol Ther
. 2015 Apr;
41(11):1079-93.
PMID: 25858208
Background: It has been reported that thalidomide may be effective in treating inflammatory bowel disease (IBD). Aim: To review the evidence examining the efficacy and safety of thalidomide for inducing...
6.
7.
McSharry K, Dalzell A, Leiper K, El-Matary W
Aliment Pharmacol Ther
. 2011 Oct;
34(11-12):1282-94.
PMID: 21999607
BACKGROUND Several published studies have evaluated the efficacy of tacrolimus in the management of Crohn's disease with variable conclusions. AIM To review systematically the evidence examining the efficacy and safety...
8.
Terry A, Grogan J, Casson D, Dalzell A, El-Matary W
Aliment Pharmacol Ther
. 2011 Jun;
34(2):260-1.
PMID: 21679212
No abstract available.
9.
Kitney L, Turner J, Spady D, Malik B, El-Matary W, Persad R, et al.
Can J Gastroenterol
. 2009 Dec;
23(12):811-5.
PMID: 20011733
Background: Patients with inflammatory bowel disease (IBD) often do not take their medications as prescribed. Objective: To examine self-reported adherence rates in IBD patients at the Stollery Children's Hospital (Edmonton,...
10.
El-Matary W, Jaffray B, Scott J, Hodges S
J Pediatr Gastroenterol Nutr
. 2006 Aug;
43(2):260-2.
PMID: 16877996
No abstract available.